Medijski sadržaj
- Tweetovi
- Tweetovi i odgovori
- Medijski sadržaj, trenutna stranica.
-
We're preparing for multiple clinical data readouts across our
#neurological#raredisease platform in 2020. This year is poised to be a pivotal year for#Ovid, but more importantly for the patients and families we strive to help every day. For more info: https://bit.ly/36AGnWg pic.twitter.com/3pg7XWABhO
-
As the year comes to an end, everyone here at
#Ovid would like to say THANK YOU to all of our supporters. 2020 is poised to be an exciting year for us and we can’t wait to share it with you!#happynewyearpic.twitter.com/I47kKhkoaE
-
Did you know,
#Ovid has a#podcast series, entitled#BoldMedicine? President and CMO of Ovid, Dr. Amit Rakhit moderates and chats with different guests within the#raredisease space. Click the link below to listen today! https://apple.co/2rguipy pic.twitter.com/88PM0X1bzl
-
Click the link below to learn more about the
#clinicalstudies#Ovid is currently conducting in#Angelmansyndrome,#FragileX, and#RareEpilepsy. http://www.ovidrx.com/ pic.twitter.com/3feGKwfklE -
If your child has
#Angelmansyndrome, consider participating in#Ovid’s#NEPTUNE study. Take the pre-screener to find out if your child may qualify to participate. https://angelmanstudy.com pic.twitter.com/ThHH3bBbyl
-
A message from
@jmaxlevin to the#AngelmanSyndrome patients, families, and community that we serve. On behalf of every employee at#Ovid, we wish you a joyful holiday season and a very Happy New Year.pic.twitter.com/apGUH7uO2X
-
#Ovid would like to wish the#raredisease community a#HappyHolidays!pic.twitter.com/3Titsh5pRb -
#Ovid is proud to have been a sponsor of@cureangelman Global Summit/Gala last week. We had the opportunity to discuss updates on our OV101#clinicalstudies and meet amazing families and listen to their stories!#FASTsummit2019pic.twitter.com/hRvUm6gTfJ
-
Reminder:
@AmitR_nyc will be following up his presentation at@cureangelman with a#twitterchat here on#Ovid’s handle TODAY at 1:30 pm EST. Tune in and reply below with your questions!#FASTsummit2019#Angelmansyndrome#rarediseasepic.twitter.com/4hLWTvRU77
-
Reminder:
@AmitR_nyc will be following up his presentation at@cureangelman with a#twitterchat here on#Ovid’s handle on 12/9 at 1:30 pm EST. Tune in and reply below with your questions!#FASTsummit2019#Angelmansyndrome#rarediseasepic.twitter.com/9qxPBi2N7k
-
Did you catch
@AmitR_nyc’s presentation? Join us on 12/9 at 1:30 pm EST for a follow up conversation with Amit! Reply below with your questions and he’ll do his best to respond!#FASTsummit2019#Angelmansyndrome@cureangelmanpic.twitter.com/KU3CI0Wbm7
-
It’s the time of the year when families come together and show their appreciation for one another. Don’t forget the special
#caregivers in your lives.#CaregiversMonth Retweet with a story of appreciation for a caregiver you know.#BeCareCuriouspic.twitter.com/evMPInZawp
-
Does your child have
#Angelmansyndrome? If so, consider participating in#Ovid’s NEPTUNE, a#pediatric#clinicalstudy. To learn more, visit: https://angelmanstudy.com pic.twitter.com/0xtYtjevyw
-
NEPTUNE is a
#pediatric#clinicalstudy that is evaluating OV101 to determine if the investigational medicine improves symptoms of AS of symptoms, such as the ability to sleep, behavior, and communication. To learn more about all facets of the study, visit: https://bit.ly/2oFiBSX pic.twitter.com/Splad6PRbv
-
Are you a
#patient,#caregiver,#healthcare professional or#patientadvocate looking for clinical and scientific updates related to#Ovid’s experimental therapies? Click the link below to sign up for updates. https://bit.ly/2ozRVoJ pic.twitter.com/kptpbBuF6y -
It’s National
#EpilepsyAwareness Month so let’s look at the numbers. Retweet and join us in helping to raise awareness!pic.twitter.com/CYDxEp0Tgf
-
If you’re a member of the 14% of
#caregivers who care for a child living with an illness, comment below to share your story!#CaregiversMonth@CaregiverAlly#BeCareCuriouspic.twitter.com/mk25Rjop00
Prikaži ovu nit -
We are excited to welcome Jason Tardio to
#Ovid as our COO! Jason is a seasoned leader with extensive experience in the#CNS and#rarediseases space. He will be instrumental in helping us build a strategic foundation as we approach 2020. Read more here: https://bit.ly/35byHZy pic.twitter.com/R2zswBAYzK
-
On this
#International15qDay, learn more about#dup15q and share your knowledge about this#raredisease.pic.twitter.com/Frt2AL9M2b
-
Do you have a patient with
#Angelmansyndrome? If so, consider learning more about#Ovid’s NEPTUNE, a#pediatric#clinicalstudy, regarding whether or not your patient may be eligible to participate. Visit: https://angelmanstudy.com pic.twitter.com/FxvhiqogbE
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.